Zhongzhi Pharmaceutical Holdings Ltd. held its Annual General Meeting on 13 May 2025. During the meeting, several proposals were presented and approved. These included the approval of the audited consolidated financial statements and the reports of the directors and the auditor for the year ended 31 December 2024, as well as the declaration and payment of a final dividend of HK5 cents per ordinary share. Additionally, Mr. Lai Ying Feng was re-elected as an executive director of the company.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Zhongzhi Pharmaceutical Holdings Ltd. published the original content used to generate this news brief on May 13, 2025, and is solely responsible for the information contained therein.